Posts About: Tom O’Reilly

Our Newest Book: How to Understand and Deal with ADHD

Our Newest Book: How to Understand and Deal with ADHD We were so excited in 2025 when the publisher of Charity's first book, You Will Get Through This: A Mental Health Tool Kit, reached out and asked us to write a book about ADHD. Tom brings the lived experience as a...

March Madness: Trauma Healing is Like a Tournament Bracket

March Madness: Trauma Healing is Like a Tournament Bracket Every March, millions of people tune in to watch the chaos of the NCAA tournament. We talk about "survive and advance," the heartbreak of a buzzer-beater, and the grueling physical toll of the game. Whether...

Coping as a Neurodivergent IFS Coach

Coping as a Neurodivergent IFS Coach I have been playing a lot of Star Wars: Empire at War. How much? Enough to make my wife notice. Enough that I wonder where the time went. Enough that I feel embarrassed about how much I am playing. This video game binge took me by...

Ketamine Assisted Therapy Update

Our Experience with Ketamine Assisted Psychotherapy We get asked a lot about our experiences with Ketamine Assisted Psychotherapy (KAP), and it’s been a long time since we updated, so here’s an update: For those who are new here...Tom did IV Ketamine treatment through...

Tom’s podcast episode about IFS Coaching and ADHD is here!

Listen to Tom share about his parts through the lens of IFS and ADHD! Tom was interviewed about his experiences with ADHD, both personally and professionally, by Lisa at the Illuminated Recovery Podcast . Listen in to hear about Tom's journey with an ADHD diagnosis...

Neurodivergent Coach Reminisces on Past Passion Projects

Neurodivergent Coach Reminisces on Past Passion Projects

Neurodivergent Coach Reminisces on Past Passion Projects Today, I revisited my Nuerodivergent past passion projects through a time machine that is – my old external hard drive. I found a folder that had almost all of my old programming projects. I’m a self-taught...

FDA Reviews MDMA-Assisted Therapy

An advisory panel for the Food and Drug Administration (FDA) has voted against approving MDMA for Post-Traumatic Stress Disorder (PTSD). This is a disappointing outcome for people who believe in the effectiveness of therapeutic psychotropic medication and hope to see...